- Home
- NSTS vs GNTA Comparison
NSTS vs GNTA Comparison
Compare NSTS & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NSTS | GNTA |
|---|---|---|
| Founded | 1921 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.7M | 41.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NSTS | GNTA |
|---|---|---|
| Price | $11.75 | $1.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.5K | ★ 106.2K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,762,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 57.78 | N/A |
| 52 Week Low | $10.72 | $1.35 |
| 52 Week High | $13.32 | $10.00 |
Technical Indicators
Market Signals| Indicator | NSTS | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 62.55 | 28.85 |
| Support Level | $11.68 | $1.80 |
| Resistance Level | $11.75 | $1.77 |
| Average True Range (ATR) | 0.13 | 0.18 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 66.78 | 2.22 |
Price Performance
Historical ComparisonAbout NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.